Graham Hitman

Graham Hitman serves as Professor of Molecular Medicine and Diabetes at Queen Mary University of London's Faculty of Medicine and Dentistry, specifically within the Centre for Genomics and Child Health. Previously, he directed the Blizard Institute from 2013 to 2017 and edited Diabetic Medicine (2009-2015).

His research spans genomics of diabetes, prevention strategies, and Bayesian AI clinical decision support systems. Current projects include gene-environment interactions in South Asian pregnancies related to offspring cardiometabolic disease (funded by EU FP7), and Bayesian models for gestational diabetes/COVID-19 management (EPSRC-funded). He led the influential CARDS trial that shaped lipid-lowering guidelines in diabetes.

Prof. Hitman maintains extensive international collaborations with 337 PubMed-listed publications, 50,405 Google Scholar citations (h-index 81 as of March 2020). His clinical work includes advisory roles for Vital Signs Solutions.

• Graduated from University College Hospital Medical School (1976)
• Clinical training at King's College, St Bartholomew's, and Royal London Hospitals
• MD research on diabetes genetics under Prof. David Galton
• Lecturer/Senior Lecturer/Reader at Royal London Hospital Medical College
• Professor since 1995 at Barts and The London School of Medicine

He supervises four PhD students across Bayesian clinical decision support systems, obesity pathogenesis, and pregnancy/post-partum clinical trials.